Reviewed by Michael Gill, B. Sc.
9 Familial Hypercholesterolemia Clinical Trials Near Me
Top Hospitals for Familial Hypercholesterolemia Clinical Trials
Image of Novartis Investigative Site in Florida.
Novartis Investigative Site
Boca Raton
2Active Trials
2All Time Trials for Familial Hypercholesterolemia
2021First Familial Hypercholesterolemia Trial
Image of Excel Medical Clinical Trials LLC in Florida.
Excel Medical Clinical Trials LLC
Boca Raton
2Active Trials
2All Time Trials for Familial Hypercholesterolemia
2021First Familial Hypercholesterolemia Trial
Top Cities for Familial Hypercholesterolemia Clinical Trials
Image of Boca Raton in Florida.
Boca Raton
6Active Trials
Novartis Investigative SiteTop Active Site
Image of Cincinnati in Ohio.
Cincinnati
4Active Trials
Metabolic and Atherosclerosis Research CenterTop Active Site
Familial Hypercholesterolemia Clinical Trials by Phase of Trial
Phase 2 Familial Hypercholesterolemia Clinical Trials
2Active Familial Hypercholesterolemia Clinical Trials
2Number of Unique Treatments
5Number of Active Locations
Familial Hypercholesterolemia Clinical Trials by Age Group
Most Recent Familial Hypercholesterolemia Clinical Trials
Top Treatments for Familial Hypercholesterolemia Clinical Trials
Treatment Name
Active Familial Hypercholesterolemia Clinical Trials
All Time Trials for Familial Hypercholesterolemia
First Recorded Familial Hypercholesterolemia Trial
Inclisiran
2
4
2017
Motivational interview (MI)
1
1
2022
ARO-ANG 3 Injection
1
1
2022
Canada's Food Guide principles (CFG diet)
1
1
2022
2-Hydroxybenzylamine (2-HOBA)
1
1
2023
Recently Completed Studies with FDA Approved Treatments for Familial Hypercholesterolemia
Treatment
Year
Sponsor
Ezetimibe
2018
Sanofi
Inclisiran
2017
Novartis Pharmaceuticals

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 7th, 2021

Last Reviewed: October 4th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Warden BA, Duell PB. Inclisiran: A Novel Agent for Lowering Apolipoprotein B-containing Lipoproteins. J Cardiovasc Pharmacol. 2021 Aug 1;78(2):e157-e174. doi: 10.1097/FJC.0000000000001053. https://pubmed.ncbi.nlm.nih.gov/339905122 Warden BA, Duell PB. Inclisiran: A Novel Agent for Lowering Apolipoprotein B-containing Lipoproteins. J Cardiovasc Pharmacol. 2021 Aug 1;78(2):e157-e174. doi: 10.1097/FJC.0000000000001053. Review. https://pubmed.ncbi.nlm.nih.gov/339905123 Reijman MD, Schweizer A, Peterson ALH, Bruckert E, Stratz C, Defesche JC, Hegele RA, Wiegman A. Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia. Eur J Prev Cardiol. 2022 Jul 20;29(9):1361-1368. doi: 10.1093/eurjpc/zwac025. https://pubmed.ncbi.nlm.nih.gov/351753524 Reijman MD, Schweizer A, Peterson ALH, Bruckert E, Stratz C, Defesche JC, Hegele RA, Wiegman A. Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia. Eur J Prev Cardiol. 2022 Feb 17. pii: zwac025. doi: 10.1093/eurjpc/zwac025. [Epub ahead of print] https://pubmed.ncbi.nlm.nih.gov/35175352